The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2025-01 · 17 (1)
DOI: 10.1002/dad2.70074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 12.03.2025. Verfasst von Simone Salemme und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Metabolic and Neural Sciences University of Modena and Reggio Emilia Modena Italy. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
INTRODUCTION Knowledge gaps remain about the prognosis of mild cognitive impairment (MCI). Conversion rates to dementia vary widely, and reversion to normal cognition has gained attention. This review updates evidence on MCI conversion risk and probability of stability and reversion. METHODS We searched databases for studies on MCI prognosis with ≥3 years of follow‐up, established criteria for MCI and dementia, and performed a meta‐analysis using a random‐effects model to assess conversion risk, reversion, and stability probability. Meta‐regressions identified sources of heterogeneity and guided subgroup analysis. RESULTS From 89 studies (mean follow‐up: 5.2 years), conversion risk was 41.5% (38.3%–44.7%) in clinical and 27.0% (22.0%–32.0%) in population‐based studies, with Alzheimer's dementia as the most common outcome. Stability rates were 49.3% (clinical) and 49.8% (population). Reversion was 8.7% (clinical) and 28.2% (population). DISCUSSION Our findings highlight higher conversion in clinical settings and 30% reversion in population studies, calling for sustainable care pathway development. Highlights Prognosis for mild cognitive impairment (MCI) varies by setting; dementia risk is higher and the probability of reversion is lower in clinical‐based studies. In both clinical and population settings, cognitive stability is ≈50%. A reorganization of health services could ensure sustainable care for individuals with MCI. Significant heterogeneity in MCI studies impacts data interpretation; follow‐up length is crucial. Long‐term prognosis studies on MCI in low‐ and middle‐income countries are urgently needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Metabolic and Neural Sciences University of Modena and Reggio Emilia Modena Italy.
- International School of Advanced Studies University of Camerino Camerino Italy.
- National Centre for Disease Prevention and Health Promotion Italian National Institute of Health Rome Italy.
- School of Medicine and Surgery University of Milan-Bicocca Milan Italy.
- Department of Neuroscience Italian National Institute of Health Rome Italy.
- Neurology Unit Azienda Ospedaliero-Universitaria di Modena Modena Italy.
ORCID-Profile: Simone Salemme
Zitieren
APA
Salemme, S., Lombardo, F. L., Lacorte, E., Sciancalepore, F., Remoli, G., Bacigalupo, I., Piscopo, P., Zamboni, G., Rossini, P. M., Cappa, S. F., Perani, D., Spadin, P., Tagliavini, F., Vanacore, N., & Ancidoni, A. (2025). The prognosis of mild cognitive impairment: A systematic review and meta‐analysis. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 17(1). https://doi.org/10.1002/dad2.70074
Vancouver
Salemme S, Lombardo FL, Lacorte E, Sciancalepore F, Remoli G, Bacigalupo I, et al. The prognosis of mild cognitive impairment: A systematic review and meta‐analysis. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2025;17(1). doi:10.1002/dad2.70074
BibTeX
@article{Salemme2025,
author = {Salemme, Simone and Lombardo, Flavia Lucia and Lacorte, Eleonora and Sciancalepore, Francesco and Remoli, Giulia and Bacigalupo, Ilaria and Piscopo, Paola and Zamboni, Giovanna and Rossini, Paolo Maria and Cappa, Stefano Francesco and Perani, Daniela and Spadin, Patrizia and Tagliavini, Fabrizio and Vanacore, Nicola and Ancidoni, Antonio},
title = {The prognosis of mild cognitive impairment: A systematic review and meta‐analysis},
journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
year = {2025},
volume = {17},
number = {1},
doi = {10.1002/dad2.70074}
}
EUVIMED